Similar articles

• [Management of mineral and bone disease caused by chronic renal disease: what recommendations have contributed].

  Houillier P; National Kidney Foundation-Kidney/Dialysis Outcomes Quality Initiative. Houillier P, et al. Nephrol Ther. 2008 Sep;4 Spec No 1:2-8, 15-9. Nephrol Ther. 2008. PMID: 19031626 French. No abstract available.
• [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). KDIGO CKD-MBD Clinical Practice Guideline].

  Tsukamoto Y. Tsukamoto Y. Clin Calcium. 2010 Jul;20(7):1021-7. Clin Calcium. 2010. PMID: 20585180 Review. Japanese.
• Clinical practice guidelines for the prevention, diagnosis, evaluation and treatment of mineral and bone disorders in chronic kidney disease (CKD-MBD) in adults.

  Bellorin-Font E, Ambrosoni P, Carlini RG, Carvalho AB, Correa-Rotter R, Cueto-Manzano A, Jara A, Jorgetti V, Negri AL, Olaizola I, Salusky I, Slatopolsky E, Weisinger JR; Comité de Metabolismo Mineral y Óseo; Sociedad Latinoamericana de Nefrología e Hipertensión (SLANH). Bellorin-Font E, et al. Nefrologia. 2013;33 Suppl 1:1-28. doi: 10.3265/Nefrologia.pre2013.Feb.11945. Nefrologia. 2013. PMID: 23629678 English, Spanish.
• [KDIGO on CKD-MBD: a new classification for an old problem?].

  Cozzolino M. Cozzolino M. G Ital Nefrol. 2009 Nov-Dec;26(6):645. G Ital Nefrol. 2009. PMID: 19918741 Italian. No abstract available.
• [Outlines of K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease].

  Orita H, Akizawa T. Orita H, et al. Clin Calcium. 2004 May;14(5):693-7. Clin Calcium. 2004. PMID: 15577029 Review. Japanese.